genprowebdirectory
News
Insights
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
News
News
In Alzheimer’s, Inflammasome Drives Both Amyloid and Tau Pathology
GEN Edge
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
Neuroscience
Omega-3 Fish Oil May Be Better for Attention Than ADHD Drugs…
News
Cancer: A DNA-Ring Circus Where Oncogenes Wreak Havoc
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Insights
Bioprocessing
Gene Therapy Companies’ Demands Reshape CDMOs
Bioprocessing
Building Bioprocessing from Data
Cell Therapy
“Squeezing” Cells Could Transform Cell Therapy Manufacturing
Insights
2020 Vision: Predictions of What May Shape Precision Medicine
Insights
How to Use CRISPR for Site-Specific Epigenetic Editing in the Nervous…
A-Lists
Drug Discovery
Top 10 Pharma Companies of 2019
A-Lists
Top 25 Biotech Companies of 2019
Insights
Top 10 Asia Biopharma Clusters 2019
Brexit
Top 10 European Biopharma Clusters
GEN Edge
Top 10 U.S. Biopharma Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
GEN Edge
Dicerna, Novo Nordisk Eye 30+ Liver Targets in Up-to-$3.8B RNAi Partnership
News
Cancer: A DNA-Ring Circus Where Oncogenes Wreak Havoc
Eli Lilly
Eli Lilly Plans $400M Manufacturing Expansion
Bioprocessing
FUJIFILM Expands its Gene Therapy Services
Magazine
November 2019 Vol. 39 No. 11
Synthetic Biology Seizes New Ground in Healthcare
November 2019 Vol. 39 No. 11
Agrigenomics Yields a Next-Gen Cornucopia
November 2019 Vol. 39 No. 11
Protein-Protein Interactions Get a New Groove On
Commentary
Machine Learning Enhances Cytometry Analysis
November 2019 Vol. 39 No. 11
Biomarker Specialists Team Up, Run Up the Companion Diagnostics Score
Resources
All
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
eBooks
Detecting HCP Impurities in the Bioproduction Haystack
Posters
Inertial Microfluidics Enables Highly Consistent Separation and Concentration of Leukocytes from…
Upcoming Webinars
Shake-Up Your Cell Expansion Efforts
Upcoming Webinars
Smarter Biobank Management
Subscribe
Create a Free Account
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Home
RNA
Antisense
Antisense
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Antisense
Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B
Antisense
Injectable RNA Therapy Dramatically Improves Vision in Child Blindness
Antisense
Fluorescent Muscular Dystrophy Mouse Lights Up Potential Antisense Oligo Drugs
Antisense
Got Milk? Roche to Apply PureTech Exosomes Platform in $1B+ Collaboration
Antisense
Roche Licenses Ionis’ Antisense HD Therapy Following Groundbreaking Trial
Antisense
Biogen Pays Ionis $10M as Phase I/IIa Trial Launched for Alzheimer’s...
Antisense
Ionis Antisense Drug Meets Primary Endpoints in Phase III FAP Study
Antisense
Ionis, Ribo Partner to Develop RNA-Targeted Therapeutics in China
Antisense
Gene Silencing Drug Holds Potential to Treat Fatal Neurological Conditions
Antisense
Ionis Earns $75M Milestone from Bayer for Progress of Antisense Drug...
Antisense
Junk DNA Helps Suppress Breast Cancer
Antisense
GSK, Idera Partner on Third-Gen Antisense Drugs for Renal Disease
Antisense
Treating Muscular Dystrophy with an RNA Editing Technology
Antisense
DNA-Vitamin E Complex Works as Potent Gene Silencer
Antisense
AstraZeneca, Isis Pharma Expand Antisense Collaboration
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
